CGC working groups were commissioned in August 2015, following a successful roundtable session at the CGC Annual Meeting. Groups were developed to create consensus statements and practice guidelines for the use of genomics in the clinical care of specific tumor types which hopefully will lead to publications that positively impact the appropriate utilization and reimbursement of genomics testing in cancer. Working Group and group leaders are listed below.
CANCER SPECIFIC WORKING GROUPS
Acute Lymphoblastic Leukemia
CNS / Brain Tumors
Multiple myeloma / Plasma Cell Disorders
Renal Cell Carcinoma
Chronic Lymphocytic Leukemia
Betsy Hirsch (University of Minnesota) and Yassmine Akkari (Legacy Central Laboratory)
Azra Ligon (Harvard Medical School) and Stewart Neill (Emory University)
Min Fang (University of Washington) and Trevor Pugh (University of Toronto)
Xinjie Xu (ARUP Laboratories) and Rashmi Kanagal Shamanna (MD Anderson)
Yajuan Liu (University of Washington)
Patricia Miron (UMassMemorial Medical Center) and Alka Chaubey (Greenwood)
Ravindra Kolhe (Medical College of Georgia)
Katherine Geiersbach (Mayo Clinic)
OTHER WORKING GROUPS
Reporting practices for constitutional genomic testing
Brynn Levy (Columbia University Medical Center) & Catherine Redher (Duke)
The melanoma and breast cancer working groups are currently recruiting additional members. If you have research or clinical experience in these tumor types and are interested in participating, please contact the group leaders Dr. Kolhe (melanoma) and Dr. Geiersbach (Mayo).
The Working Groups will again meet during a roundtable session at the Annual Meeting (Denver, 2017) and lead panel discussions summarizing their groups efforts. We look forward to the roundtable session and panel presentations being a very meaningful part of the annual meeting!